Use of DurogesicD-TRANS in Cancer Pain Patients With Inadequately Controlled Pain Relief From Weak Opioids.
Phase of Trial: Phase IV
Latest Information Update: 25 Apr 2013
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors Janssen
- 02 Mar 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 02 Mar 2010 Actual initiation date (March 2007) and actual patient number (143) added as reported by ClinicalTrials.gov.
- 02 Mar 2010 Actual end date (December 2008) added as reported by ClinicalTrials.gov.